Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

RWJ-56110: design, synthesis and characterization of new peptidomimetic PAR-1 antagonist

Oct. 29, 1999

Anticoagulants remain focus of research at Warner-Lambert

Oct. 29, 1999

Warner-Lambert discloses another series of anticoagulants

Oct. 28, 1999

Warner-Lambert patents new anticoagulants with quinolinone structure

Oct. 27, 1999

First approval obtained for bivalirudin

Oct. 26, 1999

LMW heparin to be marketed in U.K. and Ireland by ICN

Oct. 26, 1999

New anticoagulants in the pipeline at DuPont

Oct. 25, 1999

Essex Pharma launches clot buster in Germany

Oct. 20, 1999

Merck's new fibrinogen receptor antagonists disclosed in recent patent

Oct. 14, 1999

BCH-2763 shows antithrombotic activity in canine model of DVT

Oct. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.